A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multinational, Clinical Trial to Evaluate the Efficacy and Safety of Ranolazine vs Placebo in Patients With Non-ST Segment Elevation Acute Coronary Syndromes

Trial Profile

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multinational, Clinical Trial to Evaluate the Efficacy and Safety of Ranolazine vs Placebo in Patients With Non-ST Segment Elevation Acute Coronary Syndromes

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2015

At a glance

  • Drugs Ranolazine (Primary) ; Ranolazine (Primary)
  • Indications Acute coronary syndromes; Arrhythmias
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms MERLIN-TIMI-36
  • Most Recent Events

    • 31 Aug 2009 Results presented at the Annual Congress of the European Society of Cardiology (ESC).
    • 07 Nov 2007 Results presented at AHA 2007.
    • 09 Oct 2007 Results reported in Circulation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top